Clinical Trials List
2025-10-01 - 2031-04-30
Phase III
Recruiting3
ICD-10G63
Polyneuropathy in diseases classified elsewhere
ICD-10G65.0
Sequelae of Guillain-Barre syndrome
ICD-10G65.1
Sequelae of other inflammatory polyneuropathy
ICD-10G65.2
Sequelae of toxic polyneuropathy
ICD-9357.4
Polyneuropathy in other diseases classified elsewhere
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yi-Chu Liao Division of Neurology
- 賴冠霖 Division of Neurology
- Kon-Ping Lin Division of Neurology
- 季康揚 Division of Neurology
- 蕭丞宗 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝珮甄 Division of Neurology
- Hong-Chou Kuo Division of Neurology
- 張國軒 Division of Neurology
- 廖洺鋒 Division of Neurology
- 洪國竣 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- SUNG-TSANG HSIEH Division of Neurology
- 林昭文 Division of Ophthalmology
- 江樸田 Division of Neurology
- Ming-Jen Lee Division of Neurology
- 薛頌儒 Division of Neurology
- YEN-HUNG LIN Division of Cardiovascular Diseases
- SHIN-JOE YEH Division of Neurology
- HSUEH-WEN HSUEH Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
125 participants
